Olodaterol Oral Inhalation

316 interactions 36 cited references

Also sold as: Striverdi Striverdi® Respimat®

About Olodaterol Oral Inhalation

Olodaterol oral inhalation is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways, which includes chronic bronchitis and emphysema). Olodaterol oral inhalation is in a class of medicatio… Read the full Olodaterol Oral Inhalation drug information page →

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir Sparfloxacin

12 Contraindicated 247 Major 57 Moderate

All (316) Contraindicated (12) Major (247) Moderate (57)

Major

Olodaterol Oral Inhalation Brimonidine Alphagan An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Buprenorphine Belbuca An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Buserelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Carteolol Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Carvedilol Coreg Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Celiprolol Reduced olodaterol exposure and reduced beta-adrenergic blockers exposure Details Olodaterol Oral Inhalation Ceritinib Zykadia An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Chloroquine Aralen® An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Chlorpromazine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Ciprofloxacin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Citalopram Celexa An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Clarithromycin Biaxin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Clofazimine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Clomipramine Anafranil An increased risk of QT interval prolongation, an increased risk of ventricular arrhythmias and potentiated cardiovascular effects Details Olodaterol Oral Inhalation Clonidine Duraclon An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Clozapine Clozaril An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Crizotinib Xalkori An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Cyclobenzaprine Amrix An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Dabrafenib Tafinlar An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Dasatinib Phyrago An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Degarelix Firmagon An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Delamanid An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Desflurane Suprane An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Desipramine Norpramin An increased risk of QT interval prolongation, an increased risk of ventricular arrhythmias and potentiated cardiovascular effects Details Olodaterol Oral Inhalation Deslorelin An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Deutetrabenazine Austedo An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Dexmethylphenidate Focalin An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Dextroamphetamine Dexedrine An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Dibenzepin Potentiated cardiovascular effects Details Olodaterol Oral Inhalation Disopyramide Norpace An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Dofetilide Tikosyn An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Dolasetron Anzemet An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Domperidone An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Donepezil Adlarity An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Dordaviprone An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Doxepin Prudoxin An increased risk of QT interval prolongation, an increased risk of ventricular arrhythmias and potentiated cardiovascular effects Details Olodaterol Oral Inhalation Droperidol An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Droxidopa Northera An increased risk of clinically significant cardiovascular effects and fatalities and an increased/potentiated sympathetic effects... Details Olodaterol Oral Inhalation Ebastine An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Olodaterol Oral Inhalation Efavirenz An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.